The Approval of Alzheimer’s Drug Leqembi and Its Implications F.D.A. Approval and Medicare Coverage The Food and Drug Administration (FDA) recently granted full approval to the Alzheimer’s drug Leqembi, marking the first time in two decades that a drug for the disease has received such approval. Despite the approval, however, the FDA also imposed a […]
